Dr. Reddy’s recalls 1k cancer drug vials over container defect: 4 things to know

Dr. Reddy’s Laboratories on Jan. 9 recalled 1,051 vials of the cancer drug Docetaxel, according to the FDA’s enforcement report for the week of Jan. 17.

Advertisement

Here are four things to know.

1. Docetaxel is a chemotherapy drug used to treat various cancers, including breast, lung, prostate and stomach cancer.

2. Dr. Reddy’s recalled the drug after receiving reports of a defect in the injection vials’ aluminum seal.

3. The drugmaker distributed the affected product nationwide in the U.S., Uzbekistan and Myanmar.

4. Dr. Reddy’s is notifying customers of the recall, which is ongoing, via letters.

More articles on supply chain:
Mylan reaffirms $1B share buyback plan
FDA: IV fluid shortage exacerbated by hurricane damage to Puerto Rico is expected to improve
Stanford Blood Center faces critical shortage of blood, notes the flu is keeping potential donors away

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Beyond the bottleneck: How health systems are improving access, flow and care continuity

Thursday, July 30
1:00 PM - 2:00 PM CDT

Presenters: Imamu Tomlinson, MD, MBA, VituityWilliam Morice II, MD, PhD, Mayo Clinic LaboratoriesJordan Dale, MD, Houston MethodistAsh Tengshe, City of HopeChris Klay, MHA, MA, PT, FACHE, Hospital Sisters Health System

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.